Literature DB >> 32270224

Feasibility of an Enhanced Recovery Protocol for Elective Pancreatoduodenectomy: A Multicenter International Cohort Study.

Didier Roulin1, Emmanuel Melloul1, Björn Erik Wellg2, Jakob Izbicki2, Dionisios Vrochides3, Mustapha Adham4, Martin Hübner1, Nicolas Demartines5.   

Abstract

BACKGROUND: The first enhanced recovery after surgery (ERAS) guidelines for pancreatoduodenectomy (PD) were developed in 2012. The study aimed to assess compliance and outcomes of an ERAS protocol for PD, to study correlation between compliance and outcomes, and to identify risk factors for complications.
METHODS: Retrospective cohort analysis is based on a prospective database, including all consecutive patients undergoing elective PD within an ERAS program in four centers: Lausanne University Hospital (Switzerland), Carolinas Medical Center (United States), Edouard Herriot Hospital (France), and University Medical Center Hamburg-Eppendorf (Germany). Patients' characteristics, postoperative outcome and ERAS compliance were assessed. Logistic regression analysis was performed to assess predictors of postoperative complications.
RESULTS: Between October 2012 and June 2017, 404 consecutive patients underwent PD. Median length of stay was 14 days with 11.3% readmission rate. Mean overall compliance was 62%, with pre-, intra- and postoperative compliance of 93%, 80% and 30%, respectively. Overall compliance ≥ 70% versus < 70% was significantly associated with a reduction in complications (p = 0.029) and length of stay (p < 0.001). Avoidance of postoperative nasogastric tube (OR = 0.31, p = 0.043), mobilization on day of surgery (OR = 0.28, p = 0.043), and mobilization more than 6 h on postoperative day 2 (OR = 0.45, p = 0.001) were independent predictors of reduced overall complications.
CONCLUSIONS: Implementation of enhanced recovery for PD is challenging, especially in the postoperative period. Overall compliance with ERAS protocol ≥ 70% was associated with decreased complications and length of stay. Specific ERAS elements, such as avoidance of postoperative nasogastric tube and early mobilization, independently improved outcomes.

Entities:  

Mesh:

Year:  2020        PMID: 32270224     DOI: 10.1007/s00268-020-05499-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  6 in total

Review 1.  Principles of enhanced recovery in gastrointestinal surgery.

Authors:  Didier Roulin; Nicolas Demartines
Journal:  Langenbecks Arch Surg       Date:  2022-07-21       Impact factor: 2.895

2.  Enhanced recovery in elderly patients undergoing pancreatic resection: A retrospective monocentric study.

Authors:  Susanna Scarsi; David Martin; Nermin Halkic; Nicolas Demartines; Didier Roulin
Journal:  Medicine (Baltimore)       Date:  2022-06-10       Impact factor: 1.817

3.  Systematic review and meta-analysis of the impact of deviations from a clinical pathway on outcomes following pancreatoduodenectomy.

Authors:  Monish Karunakaran; Pavan Kumar Jonnada; Savio George Barreto
Journal:  World J Clin Cases       Date:  2021-05-06       Impact factor: 1.337

4.  Application of an enhanced recovery after surgery pathway for distal pancreatectomy.

Authors:  Ghada Majid-Jarrar; Ismail Labgaa; Nermin Halkic; Nicolas Demartines; Martin Hübner; Didier Roulin
Journal:  BJS Open       Date:  2022-09-02

5.  Perioperative fluids and complications after pancreatoduodenectomy within an enhanced recovery pathway.

Authors:  Jérôme Gilgien; Martin Hübner; Nermin Halkic; Nicolas Demartines; Didier Roulin
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

6.  Evaluation of the Implementation of Multiple Enhanced Recovery After Surgery Pathways Across a Provincial Health Care System in Alberta, Canada.

Authors:  Gregg Nelson; Xiaoming Wang; Alison Nelson; Peter Faris; Laura Lagendyk; Tracy Wasylak; Oliver F Bathe; David Bigam; Erin Bruce; W Donald Buie; Michael Chong; Adrian Fairey; M Eric Hyndman; Anthony MacLean; Michael McCall; Sophia Pin; Haili Wang; Leah Gramlich
Journal:  JAMA Netw Open       Date:  2021-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.